BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Diabetes mellitus
,
Hippocampus
,
Doxorubicin
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
doxycycline
Summary
General Info
Curated Studies
Most Correlated Studies
Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
Liver Pharmacology and Xenobiotic Response Repertoire
Embryonal rhabdomyosarcoma SMS-CTR cells expressing CASZ1b
Prostate carcinoma 22Rv1 cells with dox-induced AR-V7 or VAV3 expression
Breast cancer MCF-7 cells with doxycycline-induced ZF-DNMT3A fusion protein expression
Explore Curated Studies Results
Literature
Most Relevant Literature
In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enteroco…
Doxycycline-induced pancreatitis: a rare finding.
Construction of a doxycycline inducible adipogenic lentiviral expression system.
Doxycycline-induced cutaneous inflammation with systemic symptoms in a patient with acne vulgaris.
Pharmacokinetic analysis of oral doxycycline in rhesus macaques.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Doxycycline for Elbow Tendinopathy
Doxycycline in Therapy of Erythema Migrans
Doxycycline Effects on Inflammation in Cystic Fibrosis
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Doxycycline In Lymphangioleiomyomatosis (LAM)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ